GENIL.E — Gen Ilac ve Saglik Urunleri Sanayi Ticaret Share News
0.000.00%
Last trade - 00:00- TRY18.09bn
- TRY23.17bn
- TRY19.18bn
Brief: Gen Ilac Says It Renews Share Buy-Back Program For Up To 5.00 Mln Shares With Allocated Funds Of 1.00 Bln Lira
Brief: Gen Ilac Says It Signs Alternative Reimbursement Contract With SGK
Brief: Turkey's Gen Ilac FY Net Profit Drops To 148.7 Mln Lira YoY
Brief: Gen Ilac Says It Proposes To Pay Cash Dividend At Gross 0.40 Lira Per Share For 2024
Brief: Gen Ilac Says It Signs Exclusive Distribution Agreement Signed With PTC Therapeutics For Drug Named Upstaza
Brief: Gen Ilac Ve Saglik Urunleri Says Authorized Company Salutem Ecza Deposu Wins Tender From State Supply Office
Brief: Gen Ilac Says It Signs Transition Agreement To Finish Distribution Relation With Biogen Inc
Brief: Gen Ilac To Provide Drugs To Salutem For Tender Worth 117.4 Mln Lira From State Supply Office
Brief: Gen Ilac Q3 Net Profit Down To 111.8 Million Lira YoY
Brief: Gen Ilac Says It Increases Shares In Neo Auvra To 35.15% From 32.4%
Brief: Gen Ilac Ve Saglik Urunleri Q2 Net Loss Widens To 181.5 Million Lira YoY
Brief: Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Says It Signs Distribution Agreement With Olainfarm Ilac
Brief: Gen Ilac Q1 Net Result Turns To Profit Of 161.7 Million Lira YoY
Brief: Gen Ilac FY Net Profit Falls To 454.6 Million Lira YoY
Brief: Gen Ilac Q3 Net Profit Rises To 316.7 Million Lira YoY
Brief: Gen Ilac Signs Agreement With Kolay Enerji Sanayi Ve Ticaret For Solar Power Plant Project With Capacity of 4.84 MW
Brief: Gen Ilac Q2 Net Profit Drops To 165.8 Million Lira YoY
Brief: Gen Ilac Signs Alternative Reimbursement Contract With SGK For SMA Drug Named As "Spinraza"
Brief: Gen Ilac Ve Saglik Q1 Net Profit Drops To 104.3 Million Lira